ReviewFrontiers in immunology2026
Mechanism of action of the sinus microbiome in postoperative recurrence of type 2 chronic rhinosinusitis and advances in targeted intervention.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The repetition of a condition following endoscopic sinus surgery (ESS) poses an important difficulty in type 2 chronic rhinosinusitis with nasal polyps (CRSwNP) therapy. The recurrent nature of the disease is probably linked to the dynamic interplay of the enduring type 2 inflammatory microenvironment and the imbalanced sinonasal microbiome. The microbiomic characteristics and pathogenic mechanisms of postoperative recurrence are systematically elaborated in this paper, indicating that recurrent CRSwNP is characterized by microbial dysbiosis featured by enrichment of Staphylococcus aureus, depletion of Corynebacterium, and reduction in α-diversity. Its core mechanisms involve superantigen-mediated immune hijacking, epithelial barrier collapse caused by microbial metabolic imbalance, and physiological tolerance mediated by biofilms. On this basis, as a scoping review, this paper further reviews the shift of intervention strategies from "broad-spectrum bactericidal" to "precise ecological restoration", including narrow-spectrum antibacterial and phage therapies targeting Staphylococcus aureus, ecological replacement therapy by supplementing nasal-specific commensal bacteria (such as Corynebacterium), and synergistic regulation strategies using biological agents such as dupilumab to indirectly reshape the microecology by inhibiting type 2 inflammation. In addition, the paper also discusses the potential of constructing postoperative recurrence prediction models based on microbial biomarkers, aiming to provide a theoretical basis for the precise and dynamic management of CRSwNP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.